By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

RespireRx (Formerly Known As Cortex Pharmaceuticals, Inc.) 

15241 Barranca Parkway

Irvine  California  92718  U.S.A.
Phone: 949-727-3157 Fax: 949-727-3657


SEARCH JOBS


Industry
Biotechnology






Company News
RespireRx (RSRX) Files September 30, 2016 Quarterly Report On Form 10-Q 11/16/2016 12:18:29 PM
RespireRx (RSRX) Retracts Efficacy Data In September 12, 2016 Press Release Announcing Preliminary Top-Line Analysis Of Safety And Efficacy Data From Duke University Phase 2A Clinicial Trial Of CX 1739 10/4/2016 10:27:39 AM
UPDATE - RespireRx (RSRX) Announces Preliminary Top-Line Analysis Of Data From Duke University Phase 2A Clinical Trial Of CX1739 9/13/2016 11:34:20 AM
RespireRx (RSRX) Announces Preliminary Top-Line Analysis Of Data From Duke University Phase 2A Clinical Trial Of CX1739 9/12/2016 12:23:06 PM
RespireRx (RSRX) To Present At Rodman & Renshaw18th Annual Global Investment Conference On September 12, 2016 9/9/2016 11:05:29 AM
RespireRx (RSRX) Announces 1-for-325 Reverse Stock Split 9/2/2016 9:49:56 AM
RespireRx (RSRX) Files June 30, 2016 Quarterly Report On Form 10-Q 8/16/2016 7:18:59 AM
RespireRx  (RSRX) To Present At The Jefferies 2016 Healthcare Conference 6/8/2016 10:27:43 AM
RespireRx  (RSRX) Files March 31, 2016 Quarterly Report On Form 10-Q 5/17/2016 12:23:34 PM
RespireRx  (RSRX), University of Alberta And University of Florida Provide Update On Collaborative Research Activities 4/1/2016 10:30:13 AM
12345678910...
//-->